BridgeBio Pharma Inc (BBIO)
25.88
+0.27
(+1.05%)
USD |
NASDAQ |
Nov 07, 16:00
25.90
+0.02
(+0.08%)
After-Hours: 20:00
BridgeBio Pharma Revenue (Annual): 9.303M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 9.303M |
December 31, 2022 | 77.65M |
December 31, 2021 | 69.72M |
Date | Value |
---|---|
December 31, 2020 | 8.249M |
December 31, 2019 | 40.56M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
8.249M
Minimum
2020
77.65M
Maximum
2022
41.10M
Average
40.56M
Median
2019
Revenue (Annual) Benchmarks
Alnylam Pharmaceuticals Inc | 1.828B |
Pfizer Inc | 58.50B |
Vertex Pharmaceuticals Inc | 9.869B |
PTC Therapeutics Inc | 937.82M |
Bristol-Myers Squibb Co | 45.01B |